Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications (Q33786866)

29 July 2017

1 reference

title

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications (English)

1 reference

29 July 2017

1 reference

essential hypertension

1 reference

1

Bianchi S

1 reference

29 July 2017

Bigazzi R

2

1 reference

29 July 2017

Campese VM

series ordinal

3

1 reference

29 July 2017

publication date

1 December 1999

1 reference

American Journal of Kidney Diseases

29 July 2017

published in

1 reference

29 July 2017

volume

34

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

973-995

1 reference

AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Long-term complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Albumin excretion rate and its relation to kidney disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Meeting Report of the International Society of Hypertension Conference on Hypertension and Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal Factors Influencing Blood Pressure Threshold and Choice of Treatment for Hypertension in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of Angiotensin-Converting Enzyme Inhibition on Renal Function and Albuminuria in Normotensive Type I Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Epidemiology of microalbuminuria in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased glomerular permeability to albumin induced by exercise in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Response of urinary albumin to submaximal exercise in newly diagnosed non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Relationship of proteinuria and albuminuria to posture and to urine collection period

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria: associations with height and sex in non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Collecting urine for microalbumin assay

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

First morning urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in children with type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Screening for Microalbuminuria: Which Measurement?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Screening for early diabetic nephropathy: which sample to detect microalbuminuria?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Gender and the clinical usefulness of the albumin: creatinine ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Evaluation of a new semiquantitative stix for microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Bedside estimation of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Radioimmunoassay for Urinary Albumin Using a Single Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Albumin determination in frozen urines--underestimated results

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Storage temperature and differing methods of sample preparation in the measurement of urinary albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The prognostic significance of proteinuria: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Urinary albumin excretion and blood pressure in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Urinary albumin excretion in healthy adult subjects: Reference values and some factors affecting their interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Correlation of Office and Ambulatory Blood Pressure Measurements with Urinary Albumin and N-Acetyl- D-Glucosaminidase Excretions in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and associated cardiovascular risk factors in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Diurnal variations of blood pressure and microalbuminuria in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Value of ambulatory blood pressure monitoring in type I (insulin-dependent) diabetic patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Selectivity of renal injury and proteinuria in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Regulation of Glomerular Capillary Pressure and Filtration Rate in Young Kyoto Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Glomerular hemodynamics in moderate Goldblatt hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Single-nephron pressures, flows, and resistances in hypertensive kidneys with nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal hemodynamics in human subjects and in animals with genetic hypertension during the prehypertensive stage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal Vasculature in Essential Hypertension: Racial Differences

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Intrarenal pressure and exaggerated natriuresis in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Abnormal renal hemodynamics in black salt-sensitive patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Racial factors in the incidence and causation of end-stage renal disease (ESRD).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Systemic hypertension and the kidney in black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal insufficiency in treated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Elevated albumin excretion in nonmodulating essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Association between salt sensitivity and insulin concentrations in patients with hypertension*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Salt sensitivity in hypertension. Renal and cardiovascular implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Combined renal effects of overweight and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: relevance to cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Growth factor release by smooth muscle cells is dependent on haemodynamic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in normotensives with genetic risk of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal functional reserve and microalbuminuria in offspring of hypertensive parents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Lipoproteins, cardiovascular disease, and death. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Lipoprotein(a). A genetic risk factor for premature coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Lipids and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Hypertension, hyperlipidemia, and renal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Relation between serum cholesterol and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Glomerular disease in hypercholesterolemia guinea pigs: A pathogenetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

LDL stimulates mesangial fibronectin production and chemoattractant expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The progression of renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Body composition and glucose metabolism in hypertensive middle-aged males

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Glucose metabolism in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Antihypertensive effect of insulin reduction in diabetic-hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria precedes the development of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Parental history of diabetes is associated with increased cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance and blood pressure in young black men.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Hyperinsulinemia in normotensive offspring of hypertensive parents.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Activation of smooth muscle cell outgrowth from BB/Wor rat aortas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Growth-promoting effects of diabetes and insulin on arteries. An in vivo study of rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid and its modulation by elevated extracellular glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Evidence for post-transcriptional regulation by insulin of 3-hydroxy-3-methylglutaryl coenzyme A reductase and sterol synthesis in human mononuclear leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin stimulation of cholesterol synthesis by arterial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Control of glomerular hypertension by insulin administration in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Acute effects of insulin on plasma noradrenaline and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Dual effect of insulin on plasma volume and transcapillary albumin transport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion. The role of changes in blood glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Oral glucose increases urinary albumin excretion in normal subjects but not in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal and systemic transvascular albumin leakage in severe atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased transcapillary escape rate of albumin and IgG in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of catecholamines and insulin on plasma volume and intravascular mass of albumin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased transcapillary escape rate of albumin in nondiabetic men in response to hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

von Willebrand factor and development of diabetic nephropathy in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin Sensitivity, Vascular Reactivity, and Clamp-Induced Vasodilatation in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Nitric oxide release accounts for insulin's vascular effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Ultrasonographically assessed carotid morphology and the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria and cardiovascular risk: a word of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. The Bogalusa Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Blood pressure and renal function: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effect of beta-blockade on albumin excretion rate in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effects of angiotensin II receptor blockade on remnant glomerular permselectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970002-8

7 January 2021

10.1016/S0272-6386(99)70002-8

Identifiers

DOI

1 reference

29 July 2017

1 reference